-->
The atopic dermatitis therapeutics market is poised for steady growth, with revenues projected to rise from USD 15.43 billion in 2024 to USD 29.5 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.5%.
Medical bioreactor market was valued at US$ 4.31 billion in 2024 and is projected to hit the market valuation of US$ 7.04 billion by 2033 at a CAGR of 5.80% during the forecast period 2025–2033.
Amyloidosis therapeutics market was valued at US$ 2.95 billion in 2024 and is projected to hit the market valuation of US$ 6.37 billion by 2033 at a CAGR of 9.20% during the forecast period 2025–2033.
Compartment syndrome monitoring devices market was valued at US$ 215.93 million in 2024 and is projected to hit the market valuation of US$ 448.48 million by 2033 at a CAGR of 8.46% during the forecast period 2025–2033.
Infection control surveillance solutions market was valued at US$ 838.67 million in 2024 and is projected to hit the market valuation of US$ 3,090.18 million by 2033 at a CAGR of 15.78% during the forecast period 2025–2033.
North America veterinary equipment and disposables market was valued at US$ 932.60 million in 2024 and is projected to hit the market valuation of US$ 1,711.45 million by 2033 at a CAGR of 7.20% during the forecast period 2025–2033.
Newborn eye imaging systems market was valued at US$ 1.86 billion in 2024 and is projected to hit the market valuation of US$ 3.09 billion by 2033 at a CAGR of 5.81% during the forecast period 2025–2033.
The multiple myeloma market is set for steady growth, with revenue expected to rise from USD 22.6 billion in 2024 to USD 30.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 3.3%.
Ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to hit the market valuation of US$ 16.74 billion by 2034 at a CAGR of 9.82% during the forecast period 2025–2034.
Radiation dose management market was valued at US$ 764.2 million in 2024 and is projected to hit the market valuation of US$ 2,301.3 million by 2033 at a CAGR of 13.03% during the forecast period 2025–2033.